The approval is for a first-line combination maintenance therapy for extensive-stage SCLC.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/fda-approves-lurbinectedin-combo-es-sclc-maintenance-2025a1000qnn?src=rss
Author :
Publish date : 2025-10-03 19:10:00
Copyright for syndicated content belongs to the linked Source.